Form 4: Quest Diagnostics CEO James E. Davis Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Quest Diagnostics CEO James E. Davis disposed of 2,936 shares of common stock on February 19, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 19, 2025, James E. Davis, CEO and President of Quest Diagnostics Inc., disposed of 2,936 shares of common stock.
- The transaction was executed to cover tax withholding obligations arising from the vesting of restricted stock units.
- The shares were disposed of at a price of $169.71 per share.
- Following the transaction, Davis directly owns 141,181 shares of Quest Diagnostics Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, not indicative of positive or negative sentiment towards the company's performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is a common practice where executives sell shares to cover tax obligations arising from vesting equity awards.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of transaction: James E. Davis disposed of shares to cover tax obligations. |
| 02/21/2025 | Date of signature: Sean D. Mersten, Attorney in Fact for James E. Davis, signed the document. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.